CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain/(Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2021	$ 250,967	$ 3	$ 455,210	$ (150)	$ (204,096)
Beginning Balance, Shares at Dec. 31, 2021		32,971,107
Vesting of shares of common stock subject to repurchase	6		6
Vesting of shares of common stock subject to repurchase, Shares		10,924
Issuance of common stock upon exercise of stock options	79		79
Issuance of common stock upon exercise of stock options, Shares		21,067
Share-based compensation expense	4,097		4,097
Unrealized gain (loss) on investments	(456)			(456)
Net loss	(25,987)				(25,987)
Ending Balance at Mar. 31, 2022	228,706	$ 3	459,392	(606)	(230,083)
Ending Balance, Shares at Mar. 31, 2022		33,003,098
Beginning Balance at Dec. 31, 2021	250,967	$ 3	455,210	(150)	(204,096)
Beginning Balance, Shares at Dec. 31, 2021		32,971,107
Net loss	(52,910)
Ending Balance at Jun. 30, 2022	421,041	$ 5	678,973	(931)	(257,006)
Ending Balance, Shares at Jun. 30, 2022		48,427,202
Beginning Balance at Mar. 31, 2022	228,706	$ 3	459,392	(606)	(230,083)
Beginning Balance, Shares at Mar. 31, 2022		33,003,098
Vesting of shares of common stock subject to repurchase	3		3
Vesting of shares of common stock subject to repurchase, Shares		2,387
Issuance of common stock upon exercise of stock options	334		334
Issuance of common stock upon exercise of stock options, Shares		88,383
Issuance of common stock upon secondary offering, net of issuance costs	215,334	$ 2	215,332
Issuance of common stock upon secondary offering, net of issuance costs, Shares		15,333,334
Share-based compensation expense	3,912		3,912
Unrealized gain (loss) on investments	(325)			(325)
Net loss	(26,923)				(26,923)
Ending Balance at Jun. 30, 2022	421,041	$ 5	678,973	(931)	(257,006)
Ending Balance, Shares at Jun. 30, 2022		48,427,202
Beginning Balance at Dec. 31, 2022	372,207	$ 5	690,814	(679)	(317,933)
Beginning Balance, Shares at Dec. 31, 2022		48,877,806
Vesting of shares of common stock subject to repurchase	2		2
Vesting of shares of common stock subject to repurchase, Shares		395
Issuance of common stock upon exercise of stock options	1		1
Issuance of common stock upon exercise of stock options, Shares		253
Issuance of common stock upon vesting of restricted stock units, Shares		50,469
Share-based compensation expense	4,746		4,746
Unrealized gain (loss) on investments	505			505
Net loss	(30,815)				(30,815)
Ending Balance at Mar. 31, 2023	346,646	$ 5	695,563	(174)	(348,748)
Ending Balance, Shares at Mar. 31, 2023		48,928,923
Beginning Balance at Dec. 31, 2022	372,207	$ 5	690,814	(679)	(317,933)
Beginning Balance, Shares at Dec. 31, 2022		48,877,806
Issuance of common stock upon secondary offering, net of issuance costs, Shares		0
Net loss	(64,102)
Ending Balance at Jun. 30, 2023	317,978	$ 5	700,609	(601)	(382,035)
Ending Balance, Shares at Jun. 30, 2023		49,058,234
Beginning Balance at Mar. 31, 2023	346,646	$ 5	695,563	(174)	(348,748)
Beginning Balance, Shares at Mar. 31, 2023		48,928,923
Vesting of shares of common stock subject to repurchase	1		1
Vesting of shares of common stock subject to repurchase, Shares		113
Issuance of common stock upon exercise of stock options	21		21
Issuance of common stock upon exercise of stock options, Shares		5,892
Issuance of common stock upon vesting of restricted stock units, Shares		28,074
Common stock issued under employee stock purchase plan	374		374
Common stock issued under employee stock purchase plan, Shares		95,232
Share-based compensation expense	4,650		4,650
Unrealized gain (loss) on investments	(427)			(427)
Net loss	(33,287)				(33,287)
Ending Balance at Jun. 30, 2023	$ 317,978	$ 5	$ 700,609	$ (601)	$ (382,035)
Ending Balance, Shares at Jun. 30, 2023		49,058,234